Date: 2015-01-13
Type of information: Nomination
Compound:
Company: Medday (France)
Therapeutic area: Autoimmune diseases - Neurodegenerative diseases - Neurological diseases - Rare diseases
Type agreement: nomination
Action mechanism:
Disease:
Details: * On January 13th, 2015, MedDay announced the appointment of Philippe Goupit as an independent Non-Executive Director. Mr. Goupit was, until recently, Vice President, Corporate Licenses at Sanofi. He will bring to MedDay’s Board his significant business and corporate development experience covering the biotechnology and pharmaceuticals sector. Mr. Goupit has more than 30 years’ experience in the pharmaceuticals industry and has spent over 20 years at Sanofi. His experience in business development covers M&A, as a former head of the corporate M&A group in Sanofi, and licensing activities. Philippe Goupit also served for some years as the Head of Investor Relations at Sanofi.
Financial terms:
Latest news:
